Literature DB >> 2543441

Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site.

M Gonzalez-Gronow1, J M Edelberg, S V Pizzo.   

Abstract

Specific cell surface receptors for plasminogen (Pg) are expressed by a wide variety of cell types and serve to promote fibrinolysis and local Pg proteolysis. Pg types 1 and 2, separated by chromatography on concanavalin A-Sepharose, were utilized to determine their binding to the monocytoid U937 cell line. Both forms bind in a dose-dependent manner. However, Pg 2 binds to the cellular receptor considerably better than Pg 1 and at equilibrium demonstrates approximately 10-fold greater binding. Lipoprotein a [Lp(a)], which possesses a subunit showing considerable homology to Pg, competes with Pg 2 for the Pg receptor in U937 cells. Moreover, Pg 1 is not able to displace Pg 2 from the receptor. These studies suggest that high levels of Lp(a) may alter the profibrinolytic activity at the cell surface and increase the risks of atherosclerosis and thrombosis. This hypothesis is in accord with the 2-5-fold increased risk of atherosclerosis in patients having high levels of Lp(a).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543441     DOI: 10.1021/bi00432a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

2.  Expressed hypervariable polymorphism of apolipoprotein (a).

Authors:  M I Kamboh; R E Ferrell; B A Kottke
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

Review 3.  Criteria for specific measurement of plasminogen (enzymatic; procedure) in human plasma.

Authors:  Johannes J Sidelmann; Nuala A Booth; Johannes Hoffmann; Michael E Nesheim; Steffen Rosén
Journal:  EJIFCC       Date:  2000-09-01

4.  Effect of desialylation on the biological properties of human plasminogen.

Authors:  M S Stack; S V Pizzo; M Gonzalez-Gronow
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

Review 5.  Lipoprotein (a). Heterogeneity and biological relevance.

Authors:  A M Scanu; G M Fless
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Lipoprotein (a): genetic marker for atherosclerosis?

Authors:  W C Breckenridge
Journal:  CMAJ       Date:  1990-07-15       Impact factor: 8.262

7.  Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein.

Authors:  J M Edelberg; J J Enghild; S V Pizzo; M Gonzalez-Gronow
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.

Authors:  A D MBewu; P N Durrington; M I Mackness; L Hunt; W H Turkie; J E Creamer
Journal:  Br Heart J       Date:  1994-04

9.  The influence of the nature of the asparagine 289-linked oligosaccharide on the activation by urokinase and lysine binding properties of natural and recombinant human plasminogens.

Authors:  D J Davidson; F J Castellino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.